Effect of respiratory syncytial virus infection during early infancy on the ontogeny of cytokine immune responses

Allergy and Asthma Proceedings

Volumn 23, Issue 6, 2002, Pages 399-405

  Gentile, Deborah A ^a   Skoner, David P ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

AIRWAY OBSTRUCTION; ASTHMA; CELLULAR IMMUNITY; HUMAN; IMMUNOLOGY; INFANT; INFANT WELFARE; NEWBORN; PHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; VIRUS INFECTION;

AIRWAY OBSTRUCTION; ASTHMA; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; INFANT; INFANT WELFARE; INFANT, NEWBORN; PREVALENCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS;

EID: 0036879006     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Busse WW, Banks-Schlegel SP, and Larsen GL. Effects of growth and development on lung function: models for study of childhood asthma. Am J Respir Crit Care Med 156:314-319, 1977.
2. Weiss KB, Gergen PJ, and Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 326:862-866, 1992.
3. Lawton AR, and Cooper MD. Ontogeny of immunity. In Immonologic Disorders in Infants and Children. Stiehm ER (Ed). Philadelphia. PA. W.B. Saunders Co., 1-28, 1989
4. Prescott S, Macaubas C, Smallacombe, et al. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353:196-200, 1999.
5. Holt PG, and Macaubas C. Development of long term tolerance versus sensitisation to environmental allergens during the perinatal period. Curr Opin Immunol 9:782:787, 1997.
6. Fishman S, Hobbs K, and Borish L. Molecular biology of cytokines in allergic diseases and asthma. Immunol Allergy Clin North Am 16:613-643, 1996.
7. Jarjour NN, Calhoun WJ, Kelly EAB, et al. The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am J Respir Crit Care Med 155:1515-1521, 1997.
8. Robinson DS, Hamid Q, Ying S et al Predominant Th2-like bronchoalveolar T-lymphocytes in atopic asthma. N Engl J Med 326:298-304, 1992.
9. Van Osterhout AJM, Van Ark I, Folkerts G, et al. Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. Am J Respir Crit Care Med 151:177-183, 1995.
10. Gemou-Engesaeth V, Bush A, Kay A, et al Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and Th2 type cytokine mRNA expression. Pediatrics 99:695-703, 1997.
11. Hoekstra MO, Hoekstra Y, De Reus D. et al. Interleukin-4, interferon-gamma and interleukin-5 in peripheral blood of children with moderate atopic asthma. Clin Exp Allergy 27:1254, 1997.
12. Chou C, Huang N, Hsieh K, and Chiang B. Reduced IL-12 levels correlate with decreased IFN-γ secreting T cells but not natural killer cell activity in asthmatic children. Ann Allergy Asthma Immunol 82 479-484, 1999.
13. Rinas U, Horneff G, and Wahn V. Interferon-gamma production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE levels. Pediatr Allergy Immunol 4:60-64, 1993.
14. Prescott SL, Macaubas C, Yabuhara A, et al. Developing patterns of T cell memory to environmental allergens in the first two years of life. Int Arch Allergy Immunol 113:75-79, 1997.
15. Martinez FD, Stern DA, Wright AL, et al. Association of interleukin-2 and mterferon-gamma production by blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. J Allergy Clin Immunol 96:652-660, 1995.
16. O'Harra A, Hosken N, Macatonia S, et al. The role of macrophage-and dendritic cell-derived IL-12 in ThI phenotype development Res Immunol 146:466-472, 1995.
17. Shu U, Demeure CE, Byun D-G, et al. Interleukin 12 exerts a differential effect on the maturation of neonatal and adult human CD45RO- CD4 T cells. J Clin Invest 94:1352-1358, 1994.
18. Holt PG. Primary allergic sensitization to environmental antigens: perinatal T cell priming as a determinant of responder phenotype in adulthood. J Exp Med 183:1297-1301, 1996.
19. Holt PG, Macaubas C, Cooper D, et al. Th1/Th2 switch regulation in immune responses to inhaled antigens: role of dendritic cells in the aetiology of allergic respiratory disease. In Dendritic Cells in Fundamental and Clinical Immunology. Castognoli R (Ed). New York: Plenum Publishing Co., 301-306, 1997.
20. Stingl G. and Bergstresser PR. Dendntic cells: a major story unfolds. Immunol Today 16:330, 1995.
21. Jones AC, Miles EA, Warner JO, et al. Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 7:109-116, 1996.
22. Nelson D, McMenamin C, McWilliam AS, et al. Development of airway intraepithelial dendritic cell network in the rat from class II MHC (Ia) negative precursors: differential regulation of la expression at different levels of the respiratory tract. J Exp Med 179:203-212, 1994.
23. Ridge JP, Fuchs EL, and Matsinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723-1726, 1996.
24. Holt PG, Schon-Hegrad MA, Oliver J, et al. A contiguous network of dendritic antigen presenting cells within the respiratory epithelium. Int Arch Allergy Appl Immunol 91:155, 1990.
25. Lambrecht B, Carro-Muino I, Vermaclen K, and Pauwels R. Allergen-induced changes in bone-marrow progenitor and airway dendritic cells in sensitized rats. Am J Respir Cell Mol Biol 20:116-174, 1999.
26. Lambrecht BN, Salomon B, Klatzmann D, and Pauwels RA. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160:4090-4097, 1998.
27. Lawrence TE, Millecchia LL, and Fedan JS Fluticasone proprionate and pentamide isethionate reduce airway hyperreactivity. pulmonary eosinophilia and pulmonary dendritic cell response in a guinea pig model of asthma. J Pharm Exp Ther 284:222-227, 1998.
28. Moller GM, Overbeek SE, van Helden-Meeuwsen CG, et al. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 26:517-524, 1996
29. Fokkens WJ, Vroom TM, Rijntjes E, and Muldeer PGH. Fluctuation of the number of CD-1 (T6)-positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with an isolated grass-pollen allergy, before, during, and after the grass-pollen season. J Allergy Clin Immunol 84:39-43, 1989.
30. van den Heuvel MM, Vanhee DDC, Postmus PE, et al. Functional and phenotypic differences of monocyte-derived dendritic cells from allergic and nonallergic patients. J Allergy Clin Immunol 101:90-95. 1998.
31. Trinchieri G, and Scott P. The role of interleukin-12 in the immune response, disease and therapy. Immunol Today 15:460-463, 1994.
32. van der Pouw Kraan TCTM, Boeije LCM, de Groot ER, et al. Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J Immunol 158:5560-5565, 1997.
33. Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 specific immune responses and inhibits the development of IL-4 producing Th2 cells. J Exp Med 177:1199-1204, 1993.
34. Kiniwa M, Gately M, Gubler U, et al. Recombinant interleukin-12 suppresses the synthesis of IgE by interleukin-4 stimulated human lymphocytes. J Clin Invest 90:262-266, 1992.
35. Naseer T, Minshall EM, Leung DYM, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 155:845-851, 1997.
36. Hamid QA, Schotman E, Jacobson MR, and Walker SM. Increases in IL-12 mRNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 99:254-260, 1997.
37. Gavett SH, O'Jearn DJ, Li X, et al. Interleukin-12 inhibits antigeninduced airway hyperiesponsiveness. inflammation, and Th2 cytokine expression in mice. J Exp Med 182:1527-1536, 1995.
38. Merrill JD, Sigaroudinia M, and Kohl S, Characterization of natural killer and antibody-dependent cellular cytotoxicity of preterm infants against human immunodeficiency virus-infected cells. Pediatr Res 40:498-503, 1996.
39. Suen Y, Lee SM, Chang L, et al. Decreased IL-12 and IFN-γ production from neonatal mononuclear cells: implication in the immaturity of neonatal cellular immunity. J Pediatr 37:286A, 1995.
40. Glezen WP, Taber LH, Frank Al, and Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140:543-546, 1986.
41. Stein R, Sherrill D, Morgan W, Holberg J, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354:541-545, 1999.
42. Carlsen KH. Childhood asthma and the environment. Pediatr Allergy Immunol 5:48-51, 1994.
43. Welliver RC, Wong DT, Sun M, et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 305:841-846, 1981.
44. Sigurs N, Bjarnason R, and Sigurbergsson Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Paediatr 83:151-155, 1994.
45. Noma T, Mori A, and Yoshizawa I, Induction of allergen-specific IL-2 responsiveness of lymphocytes after respiratory syncytial virus infection and prediction of onset of recurrent wheezing and bronchial asthma. J Allergy Clin Immunol 98:816-826, 1996.
46. Schwarze J, Hamelmann E, Bradley KL, et al. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 99:226-233, 1997.
47. Preston FM, Beier PL, and Pope JH. Infectious respiratory syncytial virus effectively inhibits: the proliferative T cell response to inactivated RSV in vitro. J Infect Dis 165:819-825, 1992.
48. Gentile D, Skoner D, Angelini B, et al. Diminished immune responses in adults experimentally infected with RSV. J Allergy Clin Immunol 103:S116, 1999
49. Skoner DP, Gentile DA, Doyle WJ, et al. Enhanced immediate hypersensitivity skin responses during experimental challenge with respiratory syncytial virus in adult subjects. J Allergy Clin Immunol 105:5356, 2000.
50. Tang YW, and Graham BS. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J Clin Invest 94:1953-1958, 1994.
51. Anderson LJ, Cecilia T, Potter C, et al. Cytokine response to respiratory synctial virus stimulation of human peripheral blood mononuclear cells. J Inf Dis 170:1201-1208, 1994.
52. Roman M, Calhoun WJ, Hinton KL, et al. Respiratory syncytial virus infection in infants is associated with predominant Th2 like response. Am J Respir Crit Care Med 156:190-195, 1997.
53. Renzi P, Turgeon J, Marcotte J, Drblik S, et al. Reduced interferon-γ production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med 159:1417-1422, 1999.
54. Anderson L, Tsou C, Potter C, Keyserling H, et al. Cytokine responses to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis 170:1201-1208, 1994.
55. Fugier-Vivier I, Servet-Delprat C, Rivailler P, et al. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells J Exp Med 186:813-823, 1997.
56. Blauvelt A, Chougnet C, Shearer GM, and Katz SI. Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-IL-10 antibodies and IL-12. J Clin Invest 97:1550-1555, 1996.
57. Konig B, Streckert H-J. Krusat T, and Konig W. Respiratory syncytial virus G protein modulates cytokine release from human peripheral blood mononuclear cells. J Leukoc Biol 59:403-406, 1996.
58. Tsutsumi H, Matsuda K, Sone S, et al. Respiratory syncytial virus-induced cytokine production by neonatal macrophages. Clin Exp Immunol 106:442-446, 1996.
59. Hussell T, Usman K, and Openshaw P. IL-12 treatment attenuates T helper cell type 2 and B cell responses. J Immunol 159:328-334, 1997
60. Bitko V, Velazquez A, Yang L. et al. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-KB and is inhibited by sodium salicylate and aspirin. Virology 232:369-378, 1997.
61. Hobbs K, Negri J, Klinnert M. et al. IL-10 and TGF-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 158:1958-1962, 1998.
62. Rosenwasser L. Promoter polymorphism in the candidate genes, IL-4, IL-9, TGF-beta. for atopy and asthma. Int Arch Allergy Immunol 118:268-270, 1999.
63. Noguchi E, Shibasaki M, Arinami T, Takeda K, et al. Association of asthma and the IL-4 promoter gene in Japanese. Clin Exp Allergy 28:449-453, 1998.
64. Holt PG. Environmental factors and primary T cell sensitization to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr Allergy Immunol 6:1-10, 1995.
65. von Mutius E, Martinez F, Fritzsch C, Nocolai T, et al. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 149:358-364, 1994.
66. Gergen PJ, Mullally DI, and Evans R. National survey of prevalence of asthma among children in the US. Pediatrics 81.1, 1988.
67. Olsen NJ, and Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 17:369-384, 1996.